PEPTONIC MEDICAL
PEPTONIC medical AB (publ), a medical technology company, develops and sells intimate self-care products for women. The company offers products under the VagiVital brand, including a moisturizing gel for atrophy; an intimate calming gel for rapid relief of itching and irritation; moisturizing lubricant; a pH-balancing intimate wash/conditioner; self-test kits for diagnosing pre-menopause, menopau… Read more
PEPTONIC MEDICAL (28L) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, PEPTONIC MEDICAL (28L) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
PEPTONIC MEDICAL - Net Assets Trend (None–None)
This chart illustrates how PEPTONIC MEDICAL's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for PEPTONIC MEDICAL (None–None)
The table below shows the annual net assets of PEPTONIC MEDICAL from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to PEPTONIC MEDICAL's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
PEPTONIC MEDICAL Competitors by Market Cap
The table below lists competitors of PEPTONIC MEDICAL ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Murray Cod Australia Ltd
AU:MCA
|
$14.71 Million |
|
Delta Djakarta Tbk
JK:DLTA
|
$14.71 Million |
|
Sutlej Textiles and Industries Limited
NSE:SUTLEJTEX
|
$14.72 Million |
|
Longeveron LLC
NASDAQ:LGVN
|
$14.72 Million |
|
VentriPoint Diagnostics Ltd
PINK:VPTDF
|
$14.70 Million |
|
Dreamfolks Services Limited
NSE:DREAMFOLKS
|
$14.70 Million |
|
China Changbaishan International Holdings Limited
F:CL70
|
$14.69 Million |
|
Skane mollan AB
ST:SKMO
|
$14.69 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in PEPTONIC MEDICAL's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares PEPTONIC MEDICAL's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently PEPTONIC MEDICAL utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares PEPTONIC MEDICAL's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $9,244,379,027
- Average return on equity (ROE) among peers: -92.52%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| PEPTONIC MEDICAL (28L) | €- | N/A | N/A | $14.71 Million |
| 26U (26U) | $6.75 Million | -514.32% | 1.08x | $248.33K |
| 27N0 (27N0) | $11.56 Million | -0.93% | 0.00x | $4.66K |
| China Resources Pharmaceutical Group Limited (640) | $90.18 Billion | 4.60% | 1.68x | $940.63 Million |
| CIG WIRELESS (6CW) | $27.09 Million | -110.19% | 3.19x | $56.65 Million |
| Solasia Pharma K.K (9SO) | $1.16 Billion | -167.91% | 0.18x | $34.42 Million |
| Apontis Pharma AG (APPH) | $3.46 Million | -34.21% | 7.59x | $11.70 Million |
| Akebia Therapeutics Inc (AX9) | $635.93 Million | -22.58% | 0.57x | $283.56 Million |
| Biofrontera AG (B8FK) | $-12.89 Million | 0.00% | 0.00x | $3.86 Million |
| AVALA RES (CVJ) | $91.87 Million | -27.32% | 0.11x | $113.22K |
| Deciphera Pharmaceuticals Inc (D05) | $341.69 Million | -52.37% | 0.33x | $2.11 Billion |